Cited by 12Gene expression and cancer classificationBioinformatics and Genomic NetworksBreast Cancer Treatment Studies

wMKL: multi-omics data integration enables novel cancer subtype identification via weight-boosted multi-kernel learning

Open access
Cao, Hongyan, Jia, Congcong, Li, Zhi, Yang, Haitao, Fang, Ruiling, Zhang, Yanbo, Cui, Yuehua·2024·British Journal of Cancer

Abstract

Background Cancer is a heterogeneous disease driven by complex molecular alterations. Cancer subtypes determined from multi-omics data can provide novel insight into personalised precision treatment. It is recognised that incorporating prior weight knowledge into multi-omics data integration can improve disease subtyping. Methods We develop a weighted method, termed weight-boosted Multi-Kernel Learning (wMKL) which incorporates heterogeneous data types as well as flexible weight functions, to boost subtype identification. Given a series of weight functions, we propose an omnibus combination strategy to integrate different weight-related P-values to improve subtyping precision. Results wMKL models each data type with multiple kernel choices, thus alleviating the sensitivity and robustness issue due to selecting kernel parameters. Furthermore, wMKL integrates different data types by learning weights of different kernels derived from each data type, recognising the heterogeneous contribution of different data types to the final subtyping performance. The proposed wMKL outperforms existing weighted and non-weighted methods. The utility and advantage of wMKL are illustrated through extensive simulations and applications to two TCGA datasets. Novel subtypes are identified followed by extensive downstream bioinformatics analysis to understand the molecular mechanisms differentiating different subtypes. Conclusions The proposed wMKL method provides a novel strategy for disease subtyping. The wMKL is freely available at https://github.com/biostatcao/wMKL .

Integrity signals

Registry

Crossref · 10.1038/s41416-024-02587-w

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MKL is commonly used in disease diagnosis and classification tasks within multi-omics studies.

    “In contrast, MKL, a supervised machine learning approach, is commonly used in disease diagnosis and classification tasks within multi-omics studies [47,48].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cao, H., Jia, C., Li, Z., Yang, H., Fang, R., Zhang, Y., & Cui, Y.
Affiliations
  • Shanxi Medical University (CN)
  • Hebei Medical University (CN)
  • Michigan State University (US)
Corresponding author
Cui, Yuehua
Venue
British Journal of Cancer
Published
2024-01-26
Volume
130
Issue
6
Pages
1001-1012
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W4391259201
Cited by
12
References
66
Citations by year
2026: 9 · 2025: 3
FWCI
1.63
Type
journal article
Language
en
Open access
Locations
  • British Journal of Cancer (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Michigan State University
  • National Natural Science Foundation of China (71403156, 81872717)
  • China Scholarship Council (201908140151)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
cancer subtyping, multi-omics integration, multiple kernel learning, weight functions, kernel parameter selection, p-value combination, tumor heterogeneity, precision oncology, TCGA cancer datasets
MeSH terms
Multiomics, Humans, Neoplasms, Computational Biology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review